drugset / Trial / NCT00004497
Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension
RandomizedDouble-blindTreatment
Summary
OBJECTIVES: I. Determine the safety and efficacy of UT-15 in patients with severe symptomatic primary pulmonary hypertension.
Timeline
- Start
- 1998-10
- Primary completion
- —
- Completion
- 2000-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Treprostinil | Other / unclassified | — | Subcutaneous |